Skip to content
Search

Latest Stories

14-year-old heart transplant campaigner champions organ donation during visit to Phoenix UK office

A 14-year-old heart transplant campaigner visited Phoenix UK's headquarters in Runcorn recently to raise awareness of the importance of organ donations.

The visit by Max Johnson, founder of  ‘Max and Keira’s law’, along with his mother Emma, coincided with the launch of Phoenix UK’s partnership with the British Heart Foundation (BHF) in which the pharmaceutical provider committed to set a donation goal of raising £20,000 by June 2023 for the heart charity.


Max and Emma met with Phoenix UK's employees and gave a talk on the importance of the work they have carried out on behalf of BHF.

Max, who was diagnosed with dilated cardiomyopathy when he was eight years old, also shared his own story. His life was saved when he was gifted with Kiera Ball’s heart – a nine-year-old girl from Devon who died in a car accident.

Max and his family campaigned tirelessly to change the law in England in favour of an opt-out system for organ donation since he was ‘gifted’ his new heart. ‘Max and Keira’s Law’ passed in May 2020.

Nigel Swift, managing director of Rowlands, Phoenix UK’s largest community pharmacy member organisation, commented: “We were thrilled to have Max and his mum visit our team and speak about the incredible work they have done in collaboration with our charity partner BHF. The visit really inspired all of the team and made everyone that bit more determined to go the extra mile to reach our £20,000 donation goal.”

Max said: “I had a good day visiting the team in Runcorn and was glad I could tell them all about my journey. It was great to hear about their work with the BHF too, as they’ve always been so supportive of our campaign.”

Emma added: “The BHF has been instrumental throughout the campaign, so it was lovely to be able to give back and inspire the Phoenix UK team to raise as much money as they can for the charity. I look forward to hearing about all the challenges the team do over the next year!”

Hayley Gough, community relationship manager at the BHF, commented: “We have funded research into heart transplants since the early 1960s and helped to turn an idea that once seemed like science fiction into a reality.

"Today, our scientists continue to investigate ways to improve the success of these operations by finding ways to protect donor hearts from rejection and help people survive longer. We are only able to carry out this crucial work because of the support that we receive from our supporters such as Phoenix UK."

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less